Clinical Trial Detail

NCT ID NCT02520427
Title A Phase 1 Study of AMG 330 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Amgen
Indications

acute myeloid leukemia

Therapies

AMG 330

Age Groups: adult senior

No variant requirements are available.